Recombinant glucagon-like peptide-1 receptor agonist (Chengdu Zhitian)
重组胰高血糖素样肽-1受体激动剂（成都芝田）
Report date: 2022/07/07 10:09:30
Base Information
Drug NameRecombinant glucagon-like peptide-1 receptor agonist (Chengdu Zhitian)
Drug Alias NameN/A
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaPending
Originator CompaniesChengdu Zhitian Biological Engineering Co Ltd
China Registration ClassClass 1 therapeutic biologic in China
Develop Information
Active CompaniesN/A
Inactive CompaniesChengdu Zhitian Biological Engineering Co Ltd
Active IndicationsN/A
Inactive Indications
Other Information
ATC CodeN/A
Related LinksN/A